Cover Image

Insight into the regulatory mechanism of β‐arrestin2 and its emerging role in diseases

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Meng Qi, Ting‐Ting Chen, Ling Li, Ping‐Ping Gao, Nan Li, Shi‐Hao Zhang, Wei Wei, Wu‐Yi Sun
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	British Journal of Pharmacology
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

AMPK activation modulates IL‐36‐induced inflammatory responses by regulating IκBζ expression in the skin
by: Yi‐Ting Huang, et al.
Published: (2024)

Circular RNA regulatory role in pathological cardiac remodelling
by: Alessia Bibi, et al.
Published: (2024)

Off‐target effects of statins: molecular mechanisms, side effects and the emerging role of kinases
by: Francisco Alejandro Lagunas‐Rangel, et al.
Published: (2024)

Differential modulation of BK channels by simvastatin: Critical role of the auxiliary β 4 subunit
by: Gangjing Li, et al.
Published: (2026)

Artemisinins in autoimmune diseases: effects and mechanisms in systemic lupus erythematosus and rheumatoid arthritis
by: Fanchao Zhou, et al.
Published: (2025)

A novel role for microtubule affinity‐regulating kinases in neuropathic pain
by: Yao‐Qin Shi, et al.
Published: (2024)

AdipoRon promotes amyloid‐β clearance through enhancing autophagy via nuclear GAPDH‐induced sirtuin 1 activation in Alzheimer's disease
by: Fengjiao Sun, et al.
Published: (2024)

Cholinergic G protein‐coupled bile acid receptor 1 (TGR5/GPBA) in the medial septal orchestrates adult hippocampal neurogenesis and cognition in Alzheimer's disease mice
by: Rui‐Zhe Nie, et al.
Published: (2025)

Astragaloside II alleviates cardiac hypertrophy by targeting aminoacylase‐1: a novel mechanism via the β ‐catenin/transcription factor 4/ubiquitin C‐terminal hydrolase L1 axis
by: Yangyang Lin, et al.
Published: (2026)

The sodium–glucose co‐transporter 2 inhibitor, empagliflozin, attenuates pulmonary vascular remodelling by inhibiting the phosphorylation of PDGF receptor‐β
by: Ting‐ting Lyu, et al.
Published: (2025)

Cancer pain: current practice and emerging targets
by: Yi Ye, et al.
Published: (2026)

Nanoliposomal Eucommia ulmoides extract limits PANoptosis in sepsis‐induced acute lung injury through a TGF‐β1–JNK pathway
by: Mingtao Deng, et al.
Published: (2026)

An agonist of the adenosine A2A receptor, CGS21680, promotes corneal epithelial wound healing via the YAP signalling pathway
by: Qiuqin Sun, et al.
Published: (2024)

Fatty acid binding protein 3 activates endothelial adhesion of circulating monocytes and impairs endothelial angiogenesis
by: Yen‐Wen Wu, et al.
Published: (2025)

Activation of autophagy mediated by PI3K/Akt/mTOR signalling cascade alleviates impaired adipose‐derived stem cell osteogenesis in a diabetic microenvironment
by: Fangzhi Lou, et al.
Published: (2025)

TREM2 activation reduces white matter injury via PI3K/Akt/GSK‐3β signalling after intracerebral haemorrhage
by: Yuan Zhang, et al.
Published: (2025)

Imperatorin ameliorates metabolic dysfunction‐associated fatty liver disease through modulating Suv39h1/Fabps/Cept1 signalling pathway
by: Yi Sun, et al.
Published: (2025)

Recent advances in neuroinflammation prevention and therapy: the role of natural products and underlying mechanisms based on molecular targets
by: Mei‐Mei Zhao, et al.
Published: (2024)

Notoginsenoside‐Fa mitigates vascular endothelial permeability via targeting SUGT1 to stabilize NLRP3 in a resting state
by: Xiao‐Ying Yu, et al.
Published: (2026)

A novel recombinant peptide, RGD‐Latcripin‐7A, targeting neovascularization in skin transplantation: Tissue regeneration and autophagy mechanism
by: Xuzi Zhang, et al.
Published: (2026)

HIF‐1α and adaptor protein LIM and senescent cell antigen‐like domains protein 1 axis promotes tubulointerstitial fibrosis by interacting with vimentin in angiotensin II‐induced hypertension
by: Wei‐Jie Ni, et al.
Published: (2024)

Elucidating the beneficial impact of exercise on chronic obstructive pulmonary disease and its comorbidities: Integrating proteomic and immunological insights
by: Xishuai Wang, et al.
Published: (2024)

Cordycepin alleviates ischaemic brain injury by suppressing microglia‐induced neuroinflammation via regulating the Notch1 signalling pathway
by: Xing Li, et al.
Published: (2026)

Correction to ‘Sphingosine‐1‐phosphate/TGF‐β axis drives epithelial mesenchymal transition in asthma‐like disease’
Published: (2024)

Photochemical control of cold‐sensitive TRPA1 ion channel gating for modulation of pain sensation
by: Junli Peng, et al.
Published: (2025)

Down‐regulation of M 6 A demethylase ALKBH5 facilitates morphine tolerance via SGK1 in mice
by: Yufei Shi, et al.
Published: (2026)

Model‐informed vancomycin precision dosing by population pharmacokinetics combined with machine learning algorithms
by: Lei Shi, et al.
Published: (2026)

Unravelling the human disposition of [ 14 C]‐vebreltinib: Faecal recovery of parent drug and a major circulating metabolite defines its mass balance profile
by: Lijun Li, et al.
Published: (2026)

First‐in‐human assessment of safety and pharmacokinetics of EP9001A:an anti‐nerve growth factor antibody for chronic pain treatment
by: Yue Cheng, et al.
Published: (2025)

Integrative immunomodulation in systemic autoimmune diseases: Mechanistic complementarity and therapeutic strategies of traditional Chinese and conventional medicine
by: Xiaomeng Zhang, et al.
Published: (2026)

Exosomes from macrophages intervened by Jiedu Yangxin decoction mediated endothelial‐to‐mesenchymal transition to improve myocardial fibrosis after myocardial infarction
by: Lingwen Cui, et al.
Published: (2026)

The NADPH oxidase inhibitor Vas2870 prevents myocyte ferroptosis and improves cardiac remodelling and function in doxorubicin‐induced cardiomyopathy
by: Jing Wang, et al.
Published: (2026)

Silibinin, a commonly used therapeutic agent for non‐alcohol fatty liver disease, functions through upregulating intestinal expression of fibroblast growth factor 15/19
by: Yujie Bai, et al.
Published: (2024)

Preclinical and translational pharmacology of afucosylated anti‐CCR8 antibody for depletion of tumour‐infiltrating regulatory T cells
by: Gautham Gampa, et al.
Published: (2024)

Ibuprofen inhibits human sweet taste and glucose detection implicating an additional mechanism of metabolic disease risk reduction
by: Emily C. Hanselman, et al.
Published: (2025)

Pharmacological targeting of large tumor suppressor kinases (LATS) 1 and 2 augments tissue repair and regeneration
by: Chen Xiao, et al.
Published: (2025)

Evaluating the clinical efficacy of combinatorial pharmacogenomic‐guided treatment in schizophrenia patients
by: Jiqing Li, et al.
Published: (2026)

Diminished nuclear‐localized β‐adrenoceptor signalling activates YAP to promote kidney fibrosis in diabetic nephropathy
by: Wenjing Xiang, et al.
Published: (2024)

V‐domain immunoglobulin suppressor of T‐cell activation and programmed death receptor 1 dual checkpoint blockade enhances antitumour immunity and survival in glioblastoma
by: Shasha Jin, et al.
Published: (2024)

Exploring drug mechanisms through single‐cell proteomics
by: Yuzhi Sun, et al.
Published: (2026)